Received Feb 12, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEP | HEP B (ENGERIX-B) | GLAXOSMITHKLINE BIOLOGICALS | UNK | UNK | — |
2-month-old patient in ICU inadvertently given HepB (Engerix-B) alone instead of Pediarix; This non-serious case was reported by a pharmacist via sales rep and described the occurrence of wrong vaccine administered in a 2-month-old female patient who received HBV (Engerix B) for prophylaxis. Co-suspect products included DTPa-HBV-IPV (Pediarix) for prophylaxis. On 07-FEB-2025, the patient received Engerix B. On an unknown date, the patient received Pediarix. On 07-FEB-2025, an unknown time after receiving Engerix B and not applicable after receiving Pediarix, the patient experienced wrong vaccine administered (Verbatim: 2-month-old patient in ICU inadvertently given HepB (Engerix-B) alone instead of Pediarix). The outcome of the wrong vaccine administered was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 07-FEB-2025 The pharmacist reported that the patient in intensive care unit (ICU) inadvertently given Hepatitis B (Engerix-B) alone instead of Pediarix, which led wrong vaccine administered. The reporter did not report any adverse effects and the infant was being monitored,